Biotricity, Inc. (BTCY)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 23.09 Million USD | 21.7% |
| 2023 | 18.97 Million USD | 477.32% |
| 2022 | 3.28 Million USD | 31.18% |
| 2021 | 2.5 Million USD | 80.45% |
| 2020 | 1.38 Million USD | 72.69% |
| 2019 | 804.05 Thousand USD | 195.31% |
| 2018 | -843.64 Thousand USD | -174.52% |
| 2017 | 1.13 Million USD | 203.37% |
| 2016 | 373.17 Thousand USD | 1175.3% |
| 2015 | 29.26 Thousand USD | 45.5% |
| 2014 | 20.11 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 23.09 Million USD | 2.62% |
| 2024 Q1 | 20.27 Million USD | 6.86% |
| 2024 FY | 23.09 Million USD | 21.7% |
| 2024 Q3 | 22.5 Million USD | 11.39% |
| 2024 Q2 | 20.2 Million USD | -0.37% |
| 2023 Q2 | 12.45 Million USD | 58.77% |
| 2023 FY | 18.97 Million USD | 477.32% |
| 2023 Q4 | 18.97 Million USD | 11.01% |
| 2023 Q3 | 17.09 Million USD | 37.25% |
| 2023 Q1 | 7.84 Million USD | 138.66% |
| 2022 Q4 | 3.28 Million USD | 278.66% |
| 2022 FY | 3.28 Million USD | 31.18% |
| 2022 Q3 | -1.83 Million USD | 79.54% |
| 2022 Q2 | -8.99 Million USD | -243.54% |
| 2022 Q1 | 6.26 Million USD | 150.03% |
| 2021 FY | 2.5 Million USD | 80.45% |
| 2021 Q1 | 3.59 Million USD | 159.16% |
| 2021 Q3 | 4.05 Million USD | 9.95% |
| 2021 Q4 | 2.5 Million USD | -38.23% |
| 2021 Q2 | 3.68 Million USD | 2.52% |
| 2020 Q3 | 227.04 Thousand USD | -94.28% |
| 2020 Q1 | 2.54 Million USD | 217.02% |
| 2020 Q4 | 1.38 Million USD | 511.58% |
| 2020 FY | 1.38 Million USD | 72.69% |
| 2020 Q2 | 3.96 Million USD | 55.64% |
| 2019 FY | 804.05 Thousand USD | 195.31% |
| 2019 Q2 | -83.25 Thousand USD | 58.92% |
| 2019 Q1 | -202.65 Thousand USD | 75.98% |
| 2019 Q4 | 804.05 Thousand USD | 10699.16% |
| 2019 Q3 | -7586.00 USD | 90.89% |
| 2018 Q2 | -607.14 Thousand USD | 49.1% |
| 2018 FY | -843.64 Thousand USD | -174.52% |
| 2018 Q4 | -843.64 Thousand USD | 66.01% |
| 2018 Q3 | -2.48 Million USD | -308.84% |
| 2018 Q1 | -1.19 Million USD | -205.36% |
| 2017 FY | 1.13 Million USD | 203.37% |
| 2017 Q1 | 1.51 Million USD | 58.68% |
| 2017 Q2 | 699.92 Thousand USD | -53.93% |
| 2017 Q3 | 1.28 Million USD | 84.03% |
| 2017 Q4 | 1.13 Million USD | -12.11% |
| 2016 Q1 | 46.23 Thousand USD | 0.0% |
| 2016 Q2 | 29.26 Thousand USD | -36.71% |
| 2016 Q3 | 373.17 Thousand USD | 1175.3% |
| 2016 Q4 | 957.45 Thousand USD | 156.57% |
| 2016 FY | 373.17 Thousand USD | 1175.3% |
| 2015 FY | 29.26 Thousand USD | 45.5% |
| 2015 Q2 | 20.11 Thousand USD | 0.0% |
| 2014 FY | 20.11 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 14.73% |
| BrainsWay Ltd. | -10.32 Million USD | 323.767% |
| Cerus Corporation | 84.35 Million USD | 72.623% |
| Envoy Medical, Inc. | -3.81 Million USD | 705.473% |
| electroCore, Inc. | -9.95 Million USD | 331.971% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 550.59% |
| IceCure Medical Ltd | -9.93 Million USD | 332.462% |
| Inogen, Inc. | -103.56 Million USD | 122.297% |
| OrthoPediatrics Corp. | -9.26 Million USD | 349.193% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 734.241% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 276.32% |
| MaxCyte, Inc. | -27.76 Million USD | 183.178% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 549.442% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 4110.777% |
| Orthofix Medical Inc. | 96.44 Million USD | 76.055% |
| PAVmed Inc | 29.08 Million USD | 20.605% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 236.329% |
| RxSight, Inc. | -6.68 Million USD | 445.7% |
| Sight Sciences, Inc. | -102.71 Million USD | 122.482% |
| SI-BONE, Inc. | 5.72 Million USD | -303.648% |
| TELA Bio, Inc. | -3.94 Million USD | 684.774% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 59.713% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -6460.435% |
| Acutus Medical, Inc. | 12.27 Million USD | -88.067% |
| Talis Biomedical Corporation | -57.06 Million USD | 140.468% |
| Spectral AI, Inc. | -3.5 Million USD | 759.604% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 148.083% |
| CVRx, Inc. | -59.95 Million USD | 138.516% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -1063.863% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -1707.456% |
| Bioventus Inc. | 372.51 Million USD | 93.801% |
| Venus Concept Inc. | 74.3 Million USD | 68.92% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 326.8% |
| LivaNova PLC | 62.53 Million USD | 63.071% |
| 908 Devices Inc. | -115.09 Million USD | 120.064% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 92.799% |
| Nemaura Medical Inc. | 9.92 Million USD | -132.672% |
| NeuroPace, Inc. | 54.33 Million USD | 57.501% |
| LENSAR, Inc. | -18.31 Million USD | 226.107% |
| Apyx Medical Corporation | -5.15 Million USD | 548.315% |
| Cutera, Inc. | 288.3 Million USD | 91.99% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -207.288% |
| BioSig Technologies, Inc. | 262 Thousand USD | -8714.019% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 152.687% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 351.035% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 98.357% |
| Axonics, Inc. | -77.19 Million USD | 129.915% |
| Outset Medical, Inc. | 67.67 Million USD | 65.879% |
| IRIDEX Corporation | -4.28 Million USD | 638.543% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 112.972% |
| IRadimed Corporation | -47.71 Million USD | 148.393% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 863.144% |
| INVO Bioscience, Inc. | 8.45 Million USD | -173.25% |
| Telesis Bio, Inc. | 32.63 Million USD | 29.239% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 1022.922% |
| Varex Imaging Corporation | 316.9 Million USD | 92.713% |
| Quipt Home Medical Corp. | 81.73 Million USD | 71.747% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 930.077% |
| Pulmonx Corporation | -42.36 Million USD | 154.515% |
| Dynatronics Corporation | 6.2 Million USD | -272.221% |
| Modular Medical, Inc. | -8.04 Million USD | 387.152% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 637.415% |
| Semler Scientific, Inc. | -57.13 Million USD | 140.421% |
| InMode Ltd. | -135.39 Million USD | 117.056% |
| Bruker Corporation | 891.3 Million USD | 97.409% |
| Cytosorbents Corporation | 4.18 Million USD | -452.191% |
| DexCom, Inc. | 2.02 Billion USD | 98.861% |
| Align Technology, Inc. | -840.47 Million USD | 102.748% |
| Viveve Medical, Inc. | -13.81 Million USD | 267.181% |
| ZimVie Inc. | 450.41 Million USD | 94.873% |
| Movano Inc. | -5.86 Million USD | 493.671% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 117.175% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 4110.777% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -1063.863% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 93.528% |
| Profound Medical Corp. | -18.17 Million USD | 227.033% |
| Insulet Corporation | 798.1 Million USD | 97.107% |
| enVVeno Medical Corporation | -2.21 Million USD | 1141.151% |
| Surmodics, Inc. | -12.01 Million USD | 292.215% |
| iCAD, Inc. | -21.2 Million USD | 208.882% |
| Nuwellis, Inc. | -2.81 Million USD | 919.182% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 75.342% |
| Aethlon Medical, Inc. | -4.5 Million USD | 612.982% |
| InspireMD, Inc. | -8.04 Million USD | 387.044% |
| PAVmed Inc. | 29.08 Million USD | 20.605% |
| BIOLASE, Inc. | 11.34 Million USD | -103.568% |
| Beyond Air, Inc. | 6.22 Million USD | -270.729% |
| FONAR Corporation | -14.66 Million USD | 257.465% |
| AxoGen, Inc. | 32.26 Million USD | 28.43% |
| Vivani Medical, Inc. | 42 Thousand USD | -54882.69% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 316.67% |
| Inari Medical, Inc. | -7.16 Million USD | 422.479% |
| UFP Technologies, Inc. | 40.77 Million USD | 43.364% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -652.543% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 583.991% |
| Tenon Medical, Inc. | -1.25 Million USD | 1940.058% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 403.612% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 293.628% |
| AdaptHealth Corp. | 2.21 Billion USD | 98.959% |
| Sintx Technologies, Inc. | 905 Thousand USD | -2451.683% |
| NanoVibronix, Inc. | -3.27 Million USD | 804.476% |
| Quanterix Corporation | -132.95 Million USD | 117.368% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 930.077% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 203.254% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 96.936% |
| TransMedics Group, Inc. | 121.13 Million USD | 80.936% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 188.208% |
| NeuroMetrix, Inc. | -1.49 Million USD | 1648.735% |
| Hyperfine, Inc. | -75.61 Million USD | 130.538% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 84.826% |
| Biomerica, Inc. | -3.38 Million USD | 782.208% |
| Bone Biologics Corporation | -3.02 Million USD | 863.0% |
| AVITA Medical, Inc. | -26.23 Million USD | 188.034% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 1356.124% |
| Silk Road Medical, Inc | 64.42 Million USD | 64.155% |